17-Aug-2026
FocalTherics Leadership Makes Bold Insider Move, Sparking Investor Buzz
TipRanks (Mon, 17-Aug 10:03 PM ET)
EDAP TMS Announces Underwritten ADS Public Offering
TipRanks (Fri, 14-Aug 6:33 AM ET)
FocalTherics Reports Second Quarter 2026 Financial Results
Globe Newswire (Thu, 13-Aug 4:02 PM ET)
Here are the major earnings after the close Thursday
Seeking Alpha News (Thu, 13-Aug 12:47 PM ET)
TipRanks (Thu, 13-Aug 10:30 AM ET)
FocalTherics Announces Pricing of Public Offering of American Depositary Shares
Globe Newswire (Tue, 11-Aug 9:10 PM ET)
FocalTherics Reports Preliminary Financial Results for Second Quarter of 2026
Globe Newswire (Tue, 11-Aug 4:28 PM ET)
FocalTherics Announces Proposed Public Offering of American Depositary Shares
Globe Newswire (Tue, 11-Aug 4:22 PM ET)
FocalTherics to Announce Second Quarter 2026 Financial Results on August 13, 2026
Globe Newswire (Thu, 30-Jul 5:00 PM ET)
Globe Newswire (Tue, 30-Jun 7:30 AM ET)
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
Edap Tms S.A. - American Depositary Shares Each Representing One Ordinary Share trades on the NASDAQ stock market under the symbol FOCL.
As of August 17, 2026, FOCL stock price declined to $4.36 with 457,974 million shares trading.
FOCL has a market cap of $163.42 million. This is considered a Micro Cap stock.
Last quarter Edap Tms S.A. - American Depositary Shares Each Representing One Ordinary Share reported $13 million in Revenue and -$.38 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.18.
FOCL support price is $4.59 and resistance is $4.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FOCL shares will trade within this expected range on the day.